Interleukin-2 Receptor alpha Subunit
"Interleukin-2 Receptor alpha Subunit" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A low affinity interleukin-2 receptor subunit that combines with the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN to form a high affinity receptor for INTERLEUKIN-2.
Descriptor ID |
D053645
|
MeSH Number(s) |
D12.776.543.750.705.852.420.320.500
|
Concept/Terms |
Interleukin-2 Receptor alpha Subunit- Interleukin-2 Receptor alpha Subunit
- Interleukin 2 Receptor alpha Subunit
- Antigens, CD25
- CD25 Antigens
- Tac P55 Peptide
- Interleukin-2 Receptor alpha
- Interleukin 2 Receptor alpha
- Receptor alpha, Interleukin-2
- Interleukin-2 Receptor alpha Chain
- Interleukin 2 Receptor alpha Chain
- Interleukin-2 Receptors alpha
- Interleukin 2 Receptors alpha
- Receptors alpha, Interleukin-2
- IL-2Ralpha
- IL 2Ralpha
- Interleukin-2Ralpha
- Interleukin 2Ralpha
- CD25 Antigen
- Antigen, CD25
- alpha-subunit, Receptor, Interleukin-2
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-2 Receptor alpha Subunit".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-2 Receptor alpha Subunit".
This graph shows the total number of publications written about "Interleukin-2 Receptor alpha Subunit" by people in this website by year, and whether "Interleukin-2 Receptor alpha Subunit" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2008 | 2 | 0 | 2 |
2009 | 0 | 1 | 1 |
2010 | 1 | 0 | 1 |
2017 | 2 | 6 | 8 |
2018 | 4 | 7 | 11 |
2019 | 1 | 1 | 2 |
2020 | 2 | 3 | 5 |
2021 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Interleukin-2 Receptor alpha Subunit" by people in Profiles.
-
Profound Treg perturbations correlate with COVID-19 severity. Proc Natl Acad Sci U S A. 2021 09 14; 118(37).
-
Fast and Efficient Genome Editing of Human FOXP3+ Regulatory T Cells. Front Immunol. 2021; 12:655122.
-
Fox3+ CD25+ CD4+ T-regulatory cells may transform the nCoV's final destiny to CNS! J Med Virol. 2021 10; 93(10):5673-5675.
-
Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns. J Intern Med. 2021 09; 290(3):677-692.
-
Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia. Cytokine. 2021 04; 140:155438.
-
Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19. Cytokine. 2021 05; 141:155428.
-
Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study. BMJ Open. 2020 11 30; 10(11):e041471.
-
Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020; 15(11):e0240784.
-
Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19. Blood Adv. 2020 10 27; 4(20):5035-5039.
-
T-Cell Hyperactivation and Paralysis in Severe COVID-19 Infection Revealed by Single-Cell Analysis. Front Immunol. 2020; 11:589380.